Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This multi-institutional retrospective cohort study aimed to describe and analyze the overall clinical characteristics, therapeutic status and prognosis pattern of gastric cancer liver metastasis (GCLM) in China.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Resectable group |
| ||
| Potentially resectable group | |||
| Unresectable group |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Gastrectomy; Hepatectomy | Procedure |
|
|
| Measure | Description | Time Frame |
|---|---|---|
| 1-year overall survival | The proportion (%) of gastric cancer liver metastasis patients that survived beyond one-year follow-up period. | 2011/01/01-2020/12/31 |
| 3-year overall survival | The proportion (%) of gastric cancer liver metastasis patients that survived beyond three-year follow-up period. | 2011/01/01-2021/12/31 |
| 5-year overall survival | The proportion (%) of gastric cancer liver metastasis patients that survived beyond five-year follow-up period. | 2011/01/01-2021/12/31 |
| Measure | Description | Time Frame |
|---|---|---|
| The incidence of gastric cancer liver metastasis cases | The rate of gastric cancer liver metastasis cases divided by all gastric cancer cases in the study period. | 2010/01/01-2019/12/31 |
| The proportion for synchronous and metachronous liver metastases cases |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
All eligible in-hospital gastric cancer liver metastases cases.
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| General Surgery Institute, China PLA General Hospital | Beijing | Beijing Municipality | 100853 | China |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 32127925 | Background | Zhang K, Chen L. Chinese consensus on the diagnosis and treatment of gastric cancer with liver metastases. Ther Adv Med Oncol. 2020 Feb 20;12:1758835920904803. doi: 10.1177/1758835920904803. eCollection 2020. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D013274 | Stomach Neoplasms |
| D009362 | Neoplasm Metastasis |
| ID | Term |
|---|---|
| D005770 | Gastrointestinal Neoplasms |
| D004067 | Digestive System Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
Not provided
Not provided
| ID | Term |
|---|---|
| D005743 | Gastrectomy |
| D006498 | Hepatectomy |
| D000078703 | Radiofrequency Ablation |
| D004358 | Drug Therapy |
| D007167 | Immunotherapy |
| ID | Term |
|---|---|
| D013505 | Digestive System Surgical Procedures |
| D013514 | Surgical Procedures, Operative |
| D000078702 | Radiofrequency Therapy |
| D013812 | Therapeutics |
Not provided
Not provided
Not provided
Not provided
Not provided
The proportion (%) of synchronous or metachronous gastric cancer liver metastases cases in all gastric cancer cases |
| 2010/01/01-2019/12/31 |
| The survival of patients that recieved different therapeutic methods | The proportion (%) of patients under different therapies that survived beyond specific follow-up period. | 2010/01/01-2019/12/31 |
| The prognostic predictive value for patients with different C-GCLM classification | The proportion (%) of patients of different classification that survived beyond specific follow-up period. | 2010/01/01-2019/12/31 |
| D004066 |
| Digestive System Diseases |
| D005767 | Gastrointestinal Diseases |
| D013272 | Stomach Diseases |
| D009385 | Neoplastic Processes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D055011 | Ablation Techniques |
| D056747 | Immunomodulation |
| D001691 | Biological Therapy |